Clinical Trial
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Investigator
Complete title:
Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy
Trial phase:
Phase
N/A
Study ID:
NCT01050504
Local study ID:
6932
Summary:
This research trial collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.
Trial keywords:
Bladder Cancer, Genitourinary Cancer, Hematologic Malignancies, Prostate Cancer, Renal Cancer, Solid Tumors, Urethral Cancer, Urogenital Neoplasms, Neoplasms, Glandular and Epithelial, Genital Neoplasms, Male, Bone Marrow Diseases
Enrollment status:
Recruiting
Trial eligibility
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Other eligibility criteria may apply.
Learn more
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact us
For more information about Fred Hutch and to schedule an appointment.
